| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-13 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |